Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Amling

Showing results (71-80 of 199) with videos related to

Pageof 20
Sort By:
Cancer|September 19, 2007
Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Joseph C Presti, et al.
The Journal of Urology|August 19, 2007
Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH databaseCharles D Scales, Joseph C Presti, Christopher J Kane, et al.
BJU International|November 22, 2008
Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?Florian R Schroeck, William J Aronson, Joseph C Presti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH databaseLionel L Bañez, Martha K Terris, William J Aronson, et al.
Urology|May 8, 2007
Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH databaseChristopher R King, Stephen J Freedland, Martha K Terris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Racial differences in prognostic value of adult height for biochemical progression following radical prostatectomyStephen J Freedland, William J Aronson, Bruce Trock, et al.
Urologic Oncology|April 4, 2020
Survival outcomes and practice trends for off-label use of adjuvant targeted therapy in high-risk locoregional renal cell carcinomaNicholas H Chakiryan, Ann Martinez Acevedo, Mark A Garzotto, et al.
European Urology|August 28, 2012
Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH databaseTammy Ho, Leah Gerber, William J Aronson, et al.
Urologic Oncology|July 13, 2019
The estimated prevalence of missed positive lymph nodes based on extent of lymphadenectomy at radical prostatectomyNicholas H Chakiryan, Ann Martinez Acevedo, Michael J Conlin, et al.
Cancer Epidemiology|October 11, 2015
Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH databaseZachary Klaassen, Lauren Howard, Martha K Terris, et al.
Pageof 20

Showing results (71-80 of 199) with videos related to

Sort By:
Pageof 20
Cancer|September 19, 2007
Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH databaseRobert J Hamilton, William J Aronson, Joseph C Presti, et al.
The Journal of Urology|August 19, 2007
Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH databaseCharles D Scales, Joseph C Presti, Christopher J Kane, et al.
BJU International|November 22, 2008
Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone?Florian R Schroeck, William J Aronson, Joseph C Presti, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 2, 2009
Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room?--Results from the SEARCH databaseLionel L Bañez, Martha K Terris, William J Aronson, et al.
Urology|May 8, 2007
Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH databaseChristopher R King, Stephen J Freedland, Martha K Terris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Racial differences in prognostic value of adult height for biochemical progression following radical prostatectomyStephen J Freedland, William J Aronson, Bruce Trock, et al.
Urologic Oncology|April 4, 2020
Survival outcomes and practice trends for off-label use of adjuvant targeted therapy in high-risk locoregional renal cell carcinomaNicholas H Chakiryan, Ann Martinez Acevedo, Mark A Garzotto, et al.
European Urology|August 28, 2012
Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH databaseTammy Ho, Leah Gerber, William J Aronson, et al.
Urologic Oncology|July 13, 2019
The estimated prevalence of missed positive lymph nodes based on extent of lymphadenectomy at radical prostatectomyNicholas H Chakiryan, Ann Martinez Acevedo, Michael J Conlin, et al.
Cancer Epidemiology|October 11, 2015
Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH databaseZachary Klaassen, Lauren Howard, Martha K Terris, et al.
Pageof 20